期刊文献+

α-苯亚甲基-β-氧代苯丙酸衍生物的合成及其醛糖还原酶抑制活性 被引量:2

Synthesis and aldose reductase inhibitory activity of α-(phenylmethylene)-β-oxo-benzenepropanoic acid derivatives
下载PDF
导出
摘要 目的设计合成新的α-苯亚甲基-β-氧代苯丙酸类化合物,并评价其对醛糖还原酶的抑制活性。方法根据具有醛糖还原酶抑制活性的查尔酮类天然产物的基本结构及醛糖还原酶抑制剂的作用机制,设计了一系列α-苯亚甲基-β-氧代苯丙酸类化合物,并以取代苯乙酮为起始原料,经3步反应得到目标产物。以依帕司他为阳性对照药,采用大鼠晶状体醛糖还原酶对目标化合物的醛糖还原酶抑制活性进行初步评价。结果合成了14个目标化合物,其中12个未见文献报道,结构经核磁共振氢谱和红外光谱确证。在浓度为1×10-4mol.L-1时,化合物9显示出较好活性,抑制率为80.48%。结论α-苯亚甲基-β-氧代苯丙酸类化合物作为新型醛糖还原酶抑制剂,其构效关系值得进一步研究。 Aim To design and synthesize novel α-(phenylmethylene)-β-oxo-benzenepropanoic acid derivatives , and to assay their inhibitory activity against aldose reductase(AR). Methods Based on the general structure of chalcone-type compounds having aldose reductase inhibitory activity and the molecular action mechanism of known aldose reductase inhibitors(ARIs), α-(phenylmethylene)-β-oxo-benzenepropanoic acid derivatives were designed , and the target compounds were synthesized via a three-step procedure starting from substituted acetophenones. Using epalrestat as a control, the aldose reductase inhibitory activity of the compounds obtained was evaluated on rat lens aldose reductase in vitro. Results Fourteen compounds were obtained and twelve of them were not reported in the literature, and their structures were characterized by ^1H-NMR and IR. Among the compounds tested, compound 9 shows an inhibitory rate of 80.48 96 under the concentration of 1×10^-4mol·L^-1. Conclusion The structure-activity relationships of α- (phenylmethylene)- β-oxo-benzenepropanoic acid derivatives as a novel type of aldose reductase inhibitor should be investigated further.
出处 《中国药物化学杂志》 CAS CSCD 2006年第1期1-5,共5页 Chinese Journal of Medicinal Chemistry
关键词 药物化学 构效关系 化学合成 α-苯亚甲基-β-氧代苯丙酸 醛糖还原酶抑制剂 medicinal chemistry structure-activity relationship chemical synthesis α- ( phenylmethylene)-β- oxo-benzenepropanoic acid aldose reductase inhibitor
  • 相关文献

参考文献9

  • 1廖二元 超楚生.内分泌学[M].北京:人民卫生出版社,2001.610-611.
  • 2Costantino L, Rastelli G, Vianello P, et al. Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches [ J ]. Med Res Rev, 1999, 19(1) :3-23.
  • 3Federico DS, Giampaolo P, Antonio DS, et al. Novel,highly potent aldose reductase inhibitors: cyano (2oxo-2, 3-dihydroindol-3-yl)acetic acid derivatives[J ],J Med Chem, 2003, 46(8):1419 - 1428.
  • 4Kaoru A, Masato T, Hideo H, et al, Isoliquiritigenin:a new aldose reductase inhibitor from Glycyrrhizae Radix[J]. Planta Med, 1990, 56(3) :254 - 258.
  • 5Lim SS, Jung SH, Ji J, et al. Synthesis of flavonoids and their effects on aldose reductsse and sorbitol accumulation in streptozotocin-induced diabetic rat tissues[ J ]. J Pharm Pharmacol, 2001,53 (5) : 653 - 668.
  • 6Urzhumtsev A, Tete-Favier F, Mitschler S, et al. A‘specificity’ pocket inferred from the crystal strueture of the complex of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil[J]. Structure, 1997, 5(5):601 - 612.
  • 7Milcent R, Malanda JC, Barbier G. Synthesis of ethyl 2-aminodihydro-5-pyrimidincarboxylate derivatives and 3, 7-diethoxycarbonyl-4, 6-dihydro-2, 4, 6, 8-tetraaryl-1H-pyrimido [ 1, 2-a] pyrimidines[J]. J Heterocycl Chem, 1997, 34( 1 ) : 329 - 336.
  • 8彭剑,顾性初,龚炳永.醛糖还原酶抑制剂的微量筛选模型的建立[J].中国医药工业杂志,1998,29(5):221-223. 被引量:12
  • 9Severi F, Benvenuti S, Costantino L, et al. Synthesis and activity of a new series of chalcone as aldose reductase inhibitors [ J ]. Eur J Med Chem, 1998, 33(11):859-866.

共引文献675

同被引文献30

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部